Contrave, designed for oral administration, has variable bioavailability: naltrexone reaches about 96% bioavailability, while bupropion achieves approximately 87% bioavailability when taken with food
GLP-1 Analog modulates appetite, taste preference, gut hormones, and regional body fat stores in adults with obesity
Recent evidence has shown that anti-amyloid drugs, another type of medication being investigated for Alzheimers disease, may be effective at combating cognitive decline, however, those drugs come with potential serious side effects, like brain bleeding and swelling
Both are part of a booming class of medications often grouped under the umbrella of GLP-1 drugs, which roughly 12% of Americans including about 1 in 5 women over 50 have used for weight loss or diabetes management